Angiogenic activity of sesamin through the activation of multiple signal pathways

Byung Hee Chung, Jung Joon Lee, Jong Dai Kim, Dooil Jeoung, Hansoo Lee, Jongseon Choe, Kwon Soo Ha, Young-Guen Kwon, Young Myeong Kim

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The natural product sesamin has been known to act as a potent antioxidant and prevent endothelial dysfunction. We here found that sesamin increased in vitro angiogenic processes, such as endothelial cell proliferation, migration, and tube formation, as well as neovascularization in an animal model. This compound elicited the activation of multiple angiogenic signal modulators, such as ERK, Akt, endothelial nitric oxide synthase (eNOS), NO production, FAK, and p38 MAPK, but not Src. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin specifically inhibited sesamin-induced activation of the ERK and Akt/eNOS pathways. These inhibitors reduced angiogenic events, with high specificity for MEK/ERK-dependent cell proliferation and migration and PI3K/Akt-mediated tube formation. Moreover, inhibition of p38 MAPK effectively inhibited sesamin-induced cell migration. The angiogenic activity of sesamin was not associated with VEGF expression. Furthermore, this compound did not induce vascular permeability and upregulated ICAM-1 and VCAM-1 expression, which are hallmarks of vascular inflammation. These results suggest that sesamin stimulates angiogenesis in vitro and in vivo through the activation of MEK/ERK-, PI3K/Akt/eNOS-, p125 FAK -, and p38 MAPK-dependent pathways, without increasing vascular inflammation, and may be used for treating ischemic diseases and tissue regeneration.

Original languageEnglish
Pages (from-to)254-260
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume391
Issue number1
DOIs
Publication statusPublished - 2010 Jan 1

Fingerprint

Signal Transduction
Chemical activation
Nitric Oxide Synthase Type III
Mitogen-Activated Protein Kinase Kinases
p38 Mitogen-Activated Protein Kinases
Phosphatidylinositol 3-Kinases
Cell Movement
Cell proliferation
Blood Vessels
Cell Proliferation
Inflammation
Tissue regeneration
Angiogenesis Inhibitors
Vascular Cell Adhesion Molecule-1
Endothelial cells
Capillary Permeability
Intercellular Adhesion Molecule-1
Biological Products
Modulators
Vascular Endothelial Growth Factor A

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Chung, Byung Hee ; Lee, Jung Joon ; Kim, Jong Dai ; Jeoung, Dooil ; Lee, Hansoo ; Choe, Jongseon ; Ha, Kwon Soo ; Kwon, Young-Guen ; Kim, Young Myeong. / Angiogenic activity of sesamin through the activation of multiple signal pathways. In: Biochemical and Biophysical Research Communications. 2010 ; Vol. 391, No. 1. pp. 254-260.
@article{6c298f115ff64b87bbb3ede69be6ca56,
title = "Angiogenic activity of sesamin through the activation of multiple signal pathways",
abstract = "The natural product sesamin has been known to act as a potent antioxidant and prevent endothelial dysfunction. We here found that sesamin increased in vitro angiogenic processes, such as endothelial cell proliferation, migration, and tube formation, as well as neovascularization in an animal model. This compound elicited the activation of multiple angiogenic signal modulators, such as ERK, Akt, endothelial nitric oxide synthase (eNOS), NO production, FAK, and p38 MAPK, but not Src. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin specifically inhibited sesamin-induced activation of the ERK and Akt/eNOS pathways. These inhibitors reduced angiogenic events, with high specificity for MEK/ERK-dependent cell proliferation and migration and PI3K/Akt-mediated tube formation. Moreover, inhibition of p38 MAPK effectively inhibited sesamin-induced cell migration. The angiogenic activity of sesamin was not associated with VEGF expression. Furthermore, this compound did not induce vascular permeability and upregulated ICAM-1 and VCAM-1 expression, which are hallmarks of vascular inflammation. These results suggest that sesamin stimulates angiogenesis in vitro and in vivo through the activation of MEK/ERK-, PI3K/Akt/eNOS-, p125 FAK -, and p38 MAPK-dependent pathways, without increasing vascular inflammation, and may be used for treating ischemic diseases and tissue regeneration.",
author = "Chung, {Byung Hee} and Lee, {Jung Joon} and Kim, {Jong Dai} and Dooil Jeoung and Hansoo Lee and Jongseon Choe and Ha, {Kwon Soo} and Young-Guen Kwon and Kim, {Young Myeong}",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.bbrc.2009.11.045",
language = "English",
volume = "391",
pages = "254--260",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

Angiogenic activity of sesamin through the activation of multiple signal pathways. / Chung, Byung Hee; Lee, Jung Joon; Kim, Jong Dai; Jeoung, Dooil; Lee, Hansoo; Choe, Jongseon; Ha, Kwon Soo; Kwon, Young-Guen; Kim, Young Myeong.

In: Biochemical and Biophysical Research Communications, Vol. 391, No. 1, 01.01.2010, p. 254-260.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Angiogenic activity of sesamin through the activation of multiple signal pathways

AU - Chung, Byung Hee

AU - Lee, Jung Joon

AU - Kim, Jong Dai

AU - Jeoung, Dooil

AU - Lee, Hansoo

AU - Choe, Jongseon

AU - Ha, Kwon Soo

AU - Kwon, Young-Guen

AU - Kim, Young Myeong

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The natural product sesamin has been known to act as a potent antioxidant and prevent endothelial dysfunction. We here found that sesamin increased in vitro angiogenic processes, such as endothelial cell proliferation, migration, and tube formation, as well as neovascularization in an animal model. This compound elicited the activation of multiple angiogenic signal modulators, such as ERK, Akt, endothelial nitric oxide synthase (eNOS), NO production, FAK, and p38 MAPK, but not Src. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin specifically inhibited sesamin-induced activation of the ERK and Akt/eNOS pathways. These inhibitors reduced angiogenic events, with high specificity for MEK/ERK-dependent cell proliferation and migration and PI3K/Akt-mediated tube formation. Moreover, inhibition of p38 MAPK effectively inhibited sesamin-induced cell migration. The angiogenic activity of sesamin was not associated with VEGF expression. Furthermore, this compound did not induce vascular permeability and upregulated ICAM-1 and VCAM-1 expression, which are hallmarks of vascular inflammation. These results suggest that sesamin stimulates angiogenesis in vitro and in vivo through the activation of MEK/ERK-, PI3K/Akt/eNOS-, p125 FAK -, and p38 MAPK-dependent pathways, without increasing vascular inflammation, and may be used for treating ischemic diseases and tissue regeneration.

AB - The natural product sesamin has been known to act as a potent antioxidant and prevent endothelial dysfunction. We here found that sesamin increased in vitro angiogenic processes, such as endothelial cell proliferation, migration, and tube formation, as well as neovascularization in an animal model. This compound elicited the activation of multiple angiogenic signal modulators, such as ERK, Akt, endothelial nitric oxide synthase (eNOS), NO production, FAK, and p38 MAPK, but not Src. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin specifically inhibited sesamin-induced activation of the ERK and Akt/eNOS pathways. These inhibitors reduced angiogenic events, with high specificity for MEK/ERK-dependent cell proliferation and migration and PI3K/Akt-mediated tube formation. Moreover, inhibition of p38 MAPK effectively inhibited sesamin-induced cell migration. The angiogenic activity of sesamin was not associated with VEGF expression. Furthermore, this compound did not induce vascular permeability and upregulated ICAM-1 and VCAM-1 expression, which are hallmarks of vascular inflammation. These results suggest that sesamin stimulates angiogenesis in vitro and in vivo through the activation of MEK/ERK-, PI3K/Akt/eNOS-, p125 FAK -, and p38 MAPK-dependent pathways, without increasing vascular inflammation, and may be used for treating ischemic diseases and tissue regeneration.

UR - http://www.scopus.com/inward/record.url?scp=72949114463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949114463&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.11.045

DO - 10.1016/j.bbrc.2009.11.045

M3 - Article

C2 - 19917268

AN - SCOPUS:72949114463

VL - 391

SP - 254

EP - 260

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -